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PENGHASILAN BIOKOMPOSIT HIDROKSIAPATIT BERKARBONAT/ 
POLI(L-LAKTIDA)/ POLI(VINIL ALKOHOL) 
 
8 ABSTRAK 
 
Hidroksiapatit berkarbonat (CHA) jenis B yang bersaiz nano telah disintesis 
melalui kaedah pengemulsian nano dengan menggunakan teknik titisan (DW) dan 
tuangan langsung (DP). Serbuk CHA daripada teknik DP mempunyai kandungan 
CO32- yang lebih tinggi dan saiz yang lebih kecil berbentuk seperti sfera, berbanding 
dengan serbuk DW dengan bentuk yang memanjang. Selain itu, saiz partikel CHA 
didapati menurun dengan peningkatan kandungan CO32-, dengan penggantian CO32- 
yang maksima, iaitu 14 wt%. Selepas itu, proses penyepuhlindapan dijalankan pada 
suhu 300900 °C dan diikuti oleh proses pengkarbonan. Pengekalan CO32- jenis B 
yang secukupnya dan kehabluran yang lebih baik dalam sampel telah dihasilkan pada 
suhu optima 700°C. Bagi penghasilan biokomposit CHA dengan poli(L-laktida) 
(PLLA) dan/atau poli(vinil alkohol) (PVA), pembentukan ikatan hidrogen antara 
kumpulan hidroksil daripada CHA dan karbonil daripada PLLA telah diperhatikan, 
manakala tiada interaksi berlaku antara CHA dengan PVA. Apabila biokomposit 
CHA/PLLA/PVA telah dihasilkan, PLLA memainkan peranan sebagai agen 
gandingan untuk mengikat CHA dan PVA melalui ikatan hidrogen. Dari aspek 
mekanikal, kekuatan tegangan garis pusat (DTS) daripada biokomposit meningkat 
dengan peningkatan kandungan polimer dan penambahan PLLA berbanding dengan 
PVA. Walau bagaimanapun, CHA/PLLA/PVA menunjukkan nilai DTS yang 
setanding pada muatan polimer yang lebih rendah. Dari aspek bioaktiviti, 
biokomposit CHA/PLLA/PVA menunjukkan kadar peresapan dan pembentukan 
apatit yang lebih baik berbanding dengan CHA/PLLA, manakala CHA/PVA adalah 
rendah dengan kehilangan berat tertinggi dalam simulasi bendalir badan. 
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DEVELOPMENT OF CARBONATED HYDROXYAPATITE/  
POLY(L-LACTIDE)/ POLY(VINYL ALCOHOL) BIOCOMPOSITES 
 
9 ABSTRACT 
 
Nanosized B-type carbonated hydroxyapatite (CHA) was successfully 
synthesized through nanoemulsion method, by both dropwise (DW) and direct 
pouring (DP) techniques. The CHA powders obtained by DP method contained 
higher CO32- content with smaller near-spherical size, as compared to the one by DW 
with elongated shape. Moreover, the CHA particle size was found to decrease with 
increasing CO32- content, with maximum CO32- substitution of 14 wt%. Annealing 
followed by carbonation at cooling stage on CHA was carried out in the range of 
300900 °C. The optimum temperature of 700°C was determined from the adequate 
B-type CO32- content retained and improved crystallinity of the annealed powder. In 
the biocomposite fabrication of CHA with poly(L-lactide) (PLLA) and/or poly(vinyl 
alcohol) (PVA), hydrogen bonding was deduced to form between hydroxyl group of 
CHA and carbonyl of PLLA, while no interaction was observed between CHA with 
PVA. When CHA/PLLA/PVA biocomposites were fabricated, PLLA served as 
coupling agent which bridged CHA and PVA via hydrogen bonding. From the 
mechanical aspect, diametral tensile strength (DTS) of the biocomposites was found 
to increase with increasing polymer loading and when PLLA was added instead of 
PVA. Nevertheless, CHA/PLLA/PVA biocomposites exhibited comparable DTS 
value at lower polymer content. In terms of bioactivity, the CHA/PLLA/PVA 
biocomposite showed better resorption rate and apatite formation as compared to 
CHA/PLLA, while CHA/PVA was low with highest weight loss in simulated body 
fluid. 
1 
 
1 CHAPTER 1 
INTRODUCTION 
 
1.1 Background 
An adult human body has 206 bones, acting as support for the body and its 
movements as well as protecting vital organs such as heart, lung and brain (Wang, 
2004). At nanostructural level, the smallest structure in bone includes non-
collagenous proteins, fibrillar collagens and embedded hydroxyapatite crystals (Chen 
and Webster, 2011). However, bones are prone to injuries, diseases, defects and 
aging, resulting from many different causes. Pielichowska and Blazewicz (2010) 
stated that even though the small defects in bone can be fixed by growth of natural 
bone, while fractures can be self-repaired by the human body, the body is however 
unable to repair large defects. Consequently, bones are one of the most commonly 
replaced tissues in human body.  
 
Synthetic bone graft is more preferable in bone reconstructing as compared to 
the biological graft as it overcomes the disadvantages of natural bone implant which 
gives trauma, donor site morbidity, risk of disease transmission and immune 
rejection (Bohner, 2010; Baino, 2011). Brydone et al. (2010) stated in their review 
that in the USA alone, there are an estimation of 280,000 hip fractures, 700,000 
vertebral, and 250,000 wrist fractures each year at a cost of $10 billion. The global 
biomaterial market is estimated to increase from $44.0 billion in 2012  $88.4 billion 
by 2017 as reported in "Biomaterials Market [By Products (Polymers, Metals, 
Ceramics, Natural Biomaterials) & Applications (Cardiovascular, Orthopedic, 
Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Ophthalmology, 
Neurology Disorders)]  Global Forecasts to 2017". The Malaysian Osteoporosis 
2 
 
Society (MOS) also expected the number of hip fracture alone to be 500,000 
annually by the year 2040. 
 
Much research work has been devoted to the production of bioresorbable 
surgical devices that could avoid surgical operation for their removal, thereby 
reducing the pain of the patients and the total cost of the treatment when compared, 
for example, to the use of metallic devices (Whang et al., 1995; Rokkanen et al., 
2000; Mathieu et al., 2006). Stress-shielding phenomena associated with the use of 
rigid metallic implants could also be minimized (Bonfield, 1988b). The continuous 
degradation of the implant causes a gradual load transfer to the healing tissue, 
preventing stress-shielding atrophy and stimulates the healing and remodelling of the 
bone (Ignatius et al., 2001; Mano et al., 2004; Zhao et al., 2008). 
 
Bonfield and colleagues firstly conceived hydroxyapatite-reinforced polymer 
biocomposites as a bone analog biomaterials enabling their properties to be tailored 
to mimic those of bone tissues (Bonfield et al., 1981; Bonfield, 1988a; Bonfield, 
1988b; Di Silvio et al., 2002).  However, biological apatites are non-stoichiometric 
hydroxyapatite (HA) as traces of ions are found in HA lattice (Barralet et al., 1998; 
Kovaleva et al., 2008). Among them, carbonate (CO32-) is the most abundant species, 
ranging from 2 to 8 wt%, depending on the individuals age (Rey et al., 1989; 
Krajewski et al., 2005; Kovaleva et al., 2008). B-type CO32- substitution which 
involves substitution of CO32- at PO43- site has higher affinity for human trabecular 
osteoblastic cell and is dominant in young tissues (Landi et al., 2000; Freiman and 
Cook, 2007). The dissolution rate of HA improves with CO32- doping, which, in turn, 
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enhances its osteointegration rate (Hasegawa et al., 2003; Morales-Nieto et al., 
2013).  
 
Of all the biodegradable polymers which show promise in biomedical field, 
poly(L-lactide) (PLLA) is the most prevalent. Not only it has good mechanical 
properties, it degrades into lactic acids which subsequently be eliminated as carbon 
dioxide (CO2) and water via Krebs cycle (Lasprilla et al., 2011). Therefore, it has 
been approved by U.S. Food and Drug Administration (FDA) to be used for a 
number of clinical applications (Engineer et al., 2011). Addition of HA into PLLA 
not only buffers the acidic resorption of PLLA, it also helps to improve its 
mechanical properties and enhances cell proliferation and alkaline phosphatise 
activity (Hutmacher, 2000; Wei and Ma, 2004; Duan et al., 2010; Wang et al., 2010). 
 
Another biodegradable polymer which has been frequently studied and 
applied in several biomedical applications is poly(vinyl alcohol) (PVA). It is 
relatively low cost biodegradable polymer with good biocompatibility, bioinert and 
hydrophilic properties. Thus, PVA is normally studied on its potential use as drug 
carrier in hydrogel form, as template for in situ precipitation of nano-sized HAp 
particles in the fabrication of a porous HA/gelatin composite (Paradossi et al., 2003; 
Sinha et al., 2003; Nayar and Sinha, 2004; Lasprilla et al., 2011).  
 
1.2 Problem Statement 
Typically, HA or carbonated hydroxyapatite (CHA) powders are incorporated 
into biodegradable polymers (PLLA and PVA) as filler rather than vice versa, i.e. as 
matrix (Shikinami and Okuno, 1999; Komlev et al., 2003; Hong et al., 2005, Yusong 
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et al., 2007; Rogel et al., 2008). However, researchers have found that acidic 
degradation of the polymers would attribute to the pH drop in-vitro or in-vivo and 
thus cause undesired environment for cells such as inflammatory during implantation 
(Schiller and Epple, 2003; Rezwan et al., 2006).  
 
 Increasing amount of HA was found to not only buffer the acidic resorption, 
it also improved the properties of biocomposites in term of mechanical properties 
and bioactivity, which is a very important characteristic for bone substitution 
applications (Hutmacher, 2000; Wang et al., 2010). However, biological apatites are 
predominantly B-CHA which have higher affinity for human trabecular osteoblastic 
cells as compared to HA and A-CHA (substitution of CO32- at OH- sites) (Rey et al., 
1989; Landi et al., 2000; Freiman and Cook, 2007). Zhou et al. (2008) had 
successfully synthesized nanosized B-CHA by nanoemulsion without any potentially 
toxic surfactant addition. This method provides reproducible narrow size distribution 
nanoparticles as well (Solans et al., 2005; Zhou et al., 2008). On other hand, porosity 
is very essential aspect for vascularization and growth of bone into an implant. 
Nevertheless, it can always be introduced by the slow removal of materials (Roeder 
et al., 2008).  
 
Therefore, in this study, biocomposites of B-type CHA with different 
loadings of PLLA and PVA were fabricated and investigated, with CHA as the 
matrix. PVA, due to its hydrophilicity, was hypothesized to be removed from the 
biocomposite first, resulting in higher porosity and providing higher surface area for 
improved dissolution and precipitation rate to induce apatite growth. PLLA, on the 
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other hand, was expected to slowly degrade along with CHA, while providing 
improved mechanical properties for the biocomposites. 
 
1.3 Objective of the Research 
The aim of this research is to produce CHA/PLLA/PVA biocomposite with 
adequate strength, good physical properties, and biocompatibility. With this main 
objective, the following studies were conducted: 
i. To synthesize B-type CHA powder via nanoemulsion by two techniques, i.e. 
dropwise and direct pouring method, to ascertain the most effective method. 
ii. To determine the optimum annealing temperature for CHA which retain 
adequate B-type carbonate content. 
iii. To prepare CHA/PLLA/PVA biocomposite in different ratios and investigate 
its physical, chemical, morphological and mechanical properties. 
iv. To evaluate the bioactivity of CHA/PLLA/PVA biocomposite via simulated 
body fluid (SBF) solution.  
 
1.4 Scope of Work 
This study is comprised of three stages of research work, starting with 
synthesis of carbonated hydroxyapatite (CHA), followed by the study of effect of 
annealing on the as-synthesized CHA powder (300900 °C), and lastly the blends of 
CHA powder with biopolymers i.e. PLLA and PVA. 
 
In the synthesis of CHA powder, two synthesis techniques, namely dropwise 
(DW) and direct pouring (DP), were applied in nanoemulsion method and compared. 
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The better synthesis technique was then carried out on the study of addition of 
various carbonate content on the properties of as-synthesized CHA powder.  
 
The optimized as-synthesized CHA powder was selected to investigate the 
influence of different annealing temperatures on the powder. Carbonation was 
employed at the end of annealing process in order to compensate the loss of 
carbonate content during the heat treatment. 
 
As for the final stage, biocomposites of optimized annealed CHA powder 
with different loading of PVA and PLLA were fabricated by powder compaction and 
heat treated. 
 
Different characterization techniques were undergone to study the physical, 
chemical, thermal and mechanical properties of CHA powder and its biocomposites. 
The bioactivity of the biocomposites was also investigated. 
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2 CHAPTER 2  
LITERATURE REVIEW 
 
2.1 Introduction 
In this chapter, review on bone is firstly introduced, followed by different 
type of bone graft substitutions (BGS), whereby the pros and cons of each method 
are compared. The advantages of carbonated hydroxyapatite (CHA) over 
stoichiometric hydroxyapatite (HA) under category bioceramics will be provided, 
and as well as the synthesis of CHA by nanoemulsion method. Then, the properties 
and production method of the two of the biodegradable polymers applied in this 
study, i.e. poly(L-lactide) (PLLA) and poly(vinyl alcohol) (PVA), are reviewed. 
Lastly, biocomposites of HA/PLLA, CHA/PLLA, and HA/PVA are presented and 
discussed. 
 
2.2 Natural Human Bone 
Bone is a substantial unit of human skeleton system, which acts as a support 
for the body and its movements (Wang, 2004), together with muscles, ligaments, and 
tendons (Park and Lakes, 2007). The hierarchy of human bone has three levels. First 
is the macrostructural level, which is divided into trabecular and compact bone. This 
is followed by a microstructural level, ranging 1-500 µm, which includes lamellae, 
cells, osteons and Harvesian systems. Lastly, at nanostructural level, the smallest 
structure in bone which includes non-collagenous proteins, fibrillar collagens and 
embedded hydroxyapatite crystals (50 x 25 x 3 nm3) (Chen and Webster, 2011). 
Figure 2.1 depicts the hierarchical organization of a bone structure. 
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Figure 2.1: The general structure of bone, showing its hierarchical organization (Luz 
and Mano, 2010) 
 
Lakes (1993) stated that at different scales, bone could be fibrous, laminar, 
particulate and porous. Apart from that, it contains bone-forming cells (osteoblasts) 
and bone-resorbing cells (osteoclasts) and various osteoconductive growth factors 
and molecules. In most bones, the major component of human bone is mineral 
substances (60-70 wt%), 20-30 wt% is of collagen and other organic components, 
while remaining is water (Weiner and Zaslansky, 2004; Currey, 2008). Table 2.1 
summarizes the comparison in chemical composition, crystal structure, and other 
properties of adult human enamel, dentine and bone.  
 
\ 
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Table 2.1: Composition and physical properties of apatites in adult human enamel, 
dentine, and bone (Park, 2008) 
Composition  Enamel  Dentine  Bone 
Calcium, Ca2+  36.5 35.1 34.1 
Phosphorus, P 17.7 16.9 15.2 
(Ca/P) molar 1.63 1.61 1.71 
Sodium, Na+ 0.5 0.6 0.9 
Magnesium, Mg2+ 0.44 1.23 0.72 
Potassium K+ 0.010 0.05 0.03 
Carbonate, CO32- 3.5 5.6 7.4 
Fluoride, F- 0.01 0.06 0.03 
Chloride, Cl- 0.30 0.01 0.13 
Pyrophosphate, P3O74- 0.022 0.10 0.07 
 
   
Total inorganic (mineral) 97.0 70.0 65.0 
Total organic 1.5 20.0 25.0 
Absorbed H2O 1.5 10.0 10.0 
Traces elements: Sr2+, Pb2+, Zn2+, 
Cu2+, Fe2+, etc.    
 
   
Crystallographic properties    
Lattice parameters (+0.0003 nm)    
a-axis 0.9441 0.9421 0.941 
c-axis 0.610100 0.610107 0.6109 
Crystallinity index 70~75 33~37 33~37 
Crystallite size (nm) 0.13 x 0.03 0.020 x 0.004 0.025 x 0.003 
 
2.2.1 Compact Bone 
The compact bone, also known as cortical bone, is dense with porosity in the 
range of 5-10%. It is normally found in the shafts of long bone (femur, tibia, fibula) 
(Currey, 1998) and outer layers of flat bones such as skulls and mandibles (Brandi, 
2009). Having four times higher mass and significant smaller surface area as 
compared to trabecular bone, compact bone is responsible for 80% of skeletal mass 
(Brandi, 2009), with density of 1.99 g/cm3 (Currey, 1998).  
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In terms of mechanical properties, it exhibits high strength and stiffness when 
load is applied at longitudinal direction (Currey, 1998; Bartel et al., 2006). All the 
above advantages render it to act as a support to body weight and to protect internal 
organ (Doll, 2005; Behari, 2009). 
 
2.2.2 Trabecular Bone 
Also referred as cancellous or spongy bone, the trabecular bone is less dense, 
with a porosity of 50-90% (Buckwalter et al., 1996). This bone can be found across 
the ends of long bones and inner parts of flat bones (Brandi, 2009). Its cross section 
appears like honeycomb and is composed of short struts of bone material called 
trabeculae (Hench and Wilson, 1993). The intertrabecular spaces of the highly 
porous trabecular bone are filled with blood vessels and cells (Behari, 2009). 
 
The mechanical properties of trabecular bone depend on the porosity of 
specimen and architectural arrangement of the individual trabeculae (Black and 
Hastings, 1998). With its finer structure and greater surface area than compact bone, 
it provides maximum support by minimum bone material. When calcium and 
phosphorous in body are insufficient, trabecular bone with higher surface area will be 
resorbed first to maintain equilibrium within the body (Doll, 2005; Behari, 2009). 
Table 2.2 compares the structural and mechanical properties of both compact and 
trabecular bone. 
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Table 2.2: Comparison between structural features and mechanical properties of 
compact and trabecular bone (Hench and Wilson, 1993; Keaveny 1998)  
Properties  Cortical bone Trabecular bone 
Volume fraction 0.85-0.95 0.05-0.60 
Surface/bone volume (mm2/mm3) 2.5 20 
Total bone volume (mm3) 1.4 x 106 0.35 x 106 
Total internal surface (mm2) 3.5 x 106 7.0 x 106 
Compressive strength (MPa) 100-230 2-12 
Flexural strength (MPa) 50-150 10-30 
Strain to failure 1-3 5-7 
Young modulus (GPa) 7-30 0.1-2.0 
 
2.2.3 Bone Graft Substitute (BGS) 
Bone grafting is a transplantation of bone to a patient by surgical operation, 
in order to repair or replace the damaged or diseased bones. Ideally, remodelling of 
bone should happen as the implant promotes new bone growth, reinforce the repaired 
area and in time, being replaced by the newly formed bone (Hing, 2005). Generally, 
there are four types of bone graft, namely autograft, allograft, xenograft, and 
synthetic graft. 
 
2.2.3.1 Autograft 
Autograft is obtained through bone transplantation from other parts of the 
patient himself. Being referred as the gold standard, this autogenous bone grafting 
offers the most biocompatible bone substitution, as the body accepts its own 
component better than from a donors (LeGeros, 2008). Besides, there is no risk of 
disease transmission and will not cause any immune rejection to the patient after 
implantation (Hing, 2005). 
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This method, however, has several disadvantages which are needed to be 
taken into serious consideration. Firstly, it requires the patient to suffer another 
surgical operation at different parts of the body, creates another defect area at harvest 
site, and has limited availability (Mata et al., 2002; LeGeros, 2008). This 
autografting is thus time-consuming and the chance of morbidity at harvest site is 
increased. Another challenging part is to obtain desired shape and size according to 
damaged area as it is hard to substitute perfectly. Another concern is the different 
resorption rate between the substituted and surrounding bones (Baino, 2011). 
 
2.2.3.2 Allograft 
Allografting, also known as allogeneic bone grafting or homografting, is the 
transplantation of bone from another living patient or cadaver to the patient (Bohner, 
2010). In modern allografting, bone used is stored within regulated bone banks and 
freeze-drying is generally used to decrease its antigenicity and extend the storage 
period (Sutherland and Bostrom, 2003). This technique has solved some drawbacks 
of autografting such as lack of donor bone site from own body, twice surgical 
operations and possible morbidity. The surgical time can thus be reduced, and pre-
forming of shape and size of transplant bone can be done. 
 
Nonetheless, allografting has concerns which include tissue availability, graft 
cost, delayed graft incorporation (body fails to accept foreign tissue), sterilization, 
and long term graft strength as well as creating pain to donor. Harvesting bone from 
living people or corpse has possible disease transmission or virus infection from 
donor. Careful checking procedure must be therefore applied, resulting in time-
consuming and cost increment of this transplant (Sutherland and Bostrom, 2003). 
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Incompatible blood group between donor and patient can induce development of 
antibodies within ABO blood group system of patient (Schnettler et al., 2006). 
 
2.2.3.3 Xenograft 
By transplanting of living cells, tissues or organs from other mammalian 
species (normally cows or pigs) to human, xenografting solves the scarcity of donor 
site. However, xenograft is not as biocompatible as autograft, and like allograft, as 
there are risks of disease and virus transmission from animal to patient and 
hyperacute rejection. Different aging rate of xenograft and human is a concern for 
this method as well (Platt et al., 1990). Moreover, perceived ethical disadvantages 
and religious beliefs (Muslim, Jewish) which prohibit the use of pigs as source also 
hinder the use of xenografting (Boneva et al., 2001; Sopyan and Algap, 2009). 
 
2.2.3.4 Synthetic Graft 
Synthetic grafts refer to the synthetic materials used as bone implant 
materials. It is widely used instead of the other grafting methods as it solves most of 
the disadvantages faced by those methods. They are mostly from family group of 
calcium phosphate (CaP), especially HA-based materials. Its shape and size can be 
tailored to perfect fitting, while its composition and resorption rate can be controlled 
to produce biocompatible and biodegradable synthetic materials. Composites of 
alloplastic materials can be produced to complement each materials shortcoming 
and give attractive properties as bone substitutes. The utilization of biodegradable 
alloplastic graft eliminates the need of second surgical operation. Problems such as 
disease transmission, morbidity and lack of bone donor site will not occur with this 
method (Bohner, 2010; Baino, 2011). 
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There is still a probability that patients body will reject CaP-based synthetic 
graft even though it is biocompatible, while the synthetic graft currently do not have 
exactly same mechanical properties as natural bone. There is potential wear on the 
implanted graft especially as joint replacement (Baino, 2011). 
 
2.3 Biomaterials 
Generally, biomaterial is defined as a synthetic material used to replace part 
of a living system or to function in intimate contact with living tissue. It substitutes 
the diseased or traumatic body part and assists in healing, improves function and 
corrects abnormalities (Park, 1995).  
 
The fundamental requirement of a biomaterial is its ability to perform 
effectively with an appropriate host response in a specific application, which can be 
termed as biocompatibility. There are three important aspects of biocompatibility 
that a candidate biomaterial seeks to achieve: 
i. biochemically compatible, non-toxic, non-irritable, non-allergenic and non-
carcinogenic, 
ii. biomechanically compatible with surrounding tissues, and 
iii. bioadhesive contact must be established between the materials and living 
tissues. 
 
During the selection of a biomaterial, its biological properties and responses 
in physiological environment are more emphasized as compared to its superior 
mechanical properties (Basu and Nath, 2009). Biomaterials can be widely 
categorized under four categories: polymers, metals, ceramics and composites, which 
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are tabulated in Table 2.3. The advantages, disadvantages and examples of each 
category of biomaterials are also presented. 
 
Table 2.3: Class of materials used in the body (Park, 1995; Park and Lakes, 2007) 
Materials Advantages Disadvantages Examples 
Polymers 
(nylon, silicone, 
rubber, polyester, 
etc) 
 
 Resilient 
 Easy to 
fabricate 
 Not strong 
 Deforms with 
time 
 May degrade 
Sutures, blood 
vessels, hip 
socket, ear, nose 
Metals  
(Ti and its alloys, 
Co-Cr alloys, Au, 
Ag stainless steels, 
etc.) 
 
 Strong 
 Tough 
 Ductile 
 
 May corrode 
 Dense 
 Difficult to 
make 
Joint 
replacements, 
dental root 
implants, pacer 
and suture wires, 
bone plates and 
screws 
 
Ceramics 
(alumina zirconia, 
CaP including HA, 
carbon) 
 
 Very 
biocompatible 
 Inert 
 Strong in 
compression 
 
 Brittle 
 Not resilient 
 Weak in tension 
Dental and 
orthopaedic 
implants 
Composites 
(carbon-carbon, 
wire- or fiber-
reinforced bone 
cement) 
 Strong 
 Tailor-made 
 Difficult to 
make 
Joint implants, 
heart valves, bone 
cement, dental 
resin 
 
2.4 Bioceramics 
Ceramics that are used to repair and replace diseased and damaged parts of 
human musculoskeletal systems are referred to as bioceramics (Thamaraiselvi and 
Rajeswari, 2004; Arcos and Vallet-Regí, 2013). These bioceramics are highly 
biocompatible as compared to polymeric or metallic biomaterials, and are often used 
as implants within bones, joints and teeth in bulk. Nonetheless, bioceramics are 
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limited to compressive load application due to its brittleness and very low tensile 
strength (TS) (Billotte, 2003; Dorozhkin, 2010a). 
 
The implantable bioceramics must be non-toxic, non-carcinogenic, non-
allergic, non-inflammatory, biocompatible, and biofunctional for its lifetime in the 
host (Bajpai and Billotte, 1995). Ceramics used in fabricating implants can be 
categorized as nonresorbable (relatively inert), bioactive or surface reactive (semi-
inert), and biodegradable or resorbable (non-inert), as displayed in Table 2.4. 
 
Table 2.4: Classification of bioceramics by implant-host response (Bajpai and 
Billotte, 1995) 
Classification  Implant-host response Examples  
Relatively bioinert 
or nonresorbable 
 Maintain physical and 
mechanical properties while in 
the host 
 Resist corrosion and wear 
Carbon, dense and 
porous alumina (Al2O3), 
zirconia (ZrO2), dense 
HA 
 
Bioactive or 
surface-reactive 
 Form strong bonds with adjacent 
tissue upon implantation in host 
Bioglasses and 
ceravital, dense glasses, 
HA 
Biodegradable or 
resorbable 
 Degrade on implantation in host 
 Replaced by endogenous tissues 
Glass fibres and their 
composites, corals, HA, 
tricalcium phosphate 
(TCP) 
 
2.4.1 Hydroxyapatite 
Ceramics and composites based on calcium phosphates are known for their 
applications as bone implants to substitute damaged or diseased bones. Amongst 
them, the stoichiometric hydroxyapatite (HA) with a chemical formula of 
Ca10(PO4)6(OH)2 has received wide attention for the past decades for its affinity to 
bone minerals and exhibits biocompatibility, bioactivity and osteoconductivity 
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(Suchanek et al., 2002; Murugan and Ramakrishna, 2006; Lafon et al., 2008; Chang 
et al., 2011). 
 
HA is a member of the apatite group of ceramics. Apatite describes a family 
of compounds having hexagonal system with space group of P63/m irrespective of 
different composition (LeGeros et al., 2009). The stoichiometric HA has Ca/P ratio 
of 1.67, and as reported in ICDD 9-432,  has unit cell dimensions of a = b = 9.418 Å 
and c = 6.884 Å, and calculated density of 3.16 g/cm3. HA structure is depicted in 
Figure 2.2. 
 
 
Figure 2.2: The HA structure viewed along the c-axis. Black lines connect Ca(I) 
columns in hexagonal networks, while cyan and magenta triangles connect staggered 
Ca(II) atoms lying in the same plane but at different height with respect to the c-axis 
(Boanini et al., 2010). 
 
The crystal structure of HA is very hospitable, allowing substitutions of 
many other ions such as F-, Cl-, CO32-, Na+, and Ba2+, for Ca2+, PO43-, or OH- groups. 
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The ionic substitutions will result in changes of properties (crystallography, lattice 
parameters, morphology, solubility, thermal stability, etc.) (LeGeros et al., 2009). 
 
Synthetic HA has been produced in granules, blocks, scaffolds, as composites 
with polymers or other ceramics, or as coatings in biomedical application. Despite its 
ability to have direct chemical bonding with bone, it has low solubility and will not 
resorb in vivo. As compared to biogenic apatite, HAs resorption is too sluggish to 
induce massive formation of new bone tissues (Ishikawa et al., 2003; Kovaleva et al., 
2008). 
 
However, HA has inadequate mechanical strength especially in aqueous 
environment, hindering its usage as load-bearing implants. As reported by Jarcho 
(1981), the Weibull factor of dense HA is 12 in wet physiological environment, 
which means that it may fail by fatigue within several months of application. Dense 
HA is very brittle, with Youngs modulus ranging from 40-117 GPa, which is 
appreciably higher than living bones (Park, 2008). Hence, the application HA is 
limited to non-load bearing prostheses, including bone filler and scaffolds for bone 
reconstruction. The mechanical properties of HA are summarized in Table 2.5.  
 
Table 2.5: Mechanical properties of synthetic HA (Park, 2008) 
Properties  Values 
Youngs modulus (GPa) 40-117 
Compressive strength (MPa) 294 
Bending strength (MPa) 147 
Hardness (Vickers, GPa) 3.43 
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2.4.2 Carbonated Hydroxyapatite 
Biological apatites have been reported to be nanosized with low crystallinity 
and contain traces of ions substituted in HA lattice, where carbonate (CO32-) is the 
most abundant species (Barralet et al., 1998; Gibson and Bonfield, 2002; Vallet-Regí 
and González-Calbet, 2004; Kovaleva et al., 2008). Hence, biological apatites are 
typically also referred as carbonated hydroxyapatite (CHA) (Merry et al., 1998; 
Heslop et al., 2005; Leventouri, 2006). 
 
The carbonate content ranges from 2 to 8%, depending on the individuals 
age (Rey et al., 1989; Bigi et al., 1997; Krajewski et al., 2005). HA may be 
chemically doped with small amount of CO32- (up to 20 mol%), whereby the 
incorporation has considerable impact on the stability of crystal lattice of HA (Best et 
al., 2008).  The dissolution rate improves with CO32- doping, in which, the local 
concentrations of Ca2+ and PO43- ions that are necessary for new bone formation are 
increased. Therefore, as compared to stoichiometric HA, CHA shows better 
bioresorbability in physiological fluid and enhanced osteointegration rate (Doi et al., 
1999; Hasegawa et al., 2003; Morales-Nieto et al., 2013). Moreover, the partial 
substitution of CO32- tends to decrease the crystallinity of HA which is closer to 
mimicking the biological bone (He et al., 2008). It is always desirable that a bone 
substitute be bioresorbable to some extent so that over a period of time, it will be 
replaced with the regenerated bone (Murugan and Ramakrishna, 2006). 
 
Possessing good bioactivity, biocompatibility and osteoconductivity 
properties, synthetic CHA has attracted much attention in tissue engineering (TE) 
field, bone graft substitution as well as dental replacement and reparation. 
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Nonetheless, the mechanical properties of apatite ceramics are less than that of the 
human cortical bone, which limits the application of CHA to non-structural implants 
(Nakamura, 1996).  
 
2.4.2.1 Classification of Carbonated Hydroxyapatite 
Classification of CHA depends on the mode of CO32- substitution in HA, 
giving A-type CHA (CO32- substitutes OH-), B-type CHA (CO32- substitutes PO43-) 
or AB-type CHA (CO32- substitutes both OH- and PO43-) (Vignoles et al., 1988; 
Gibson and Bonfield, 2002; Lafon et al., 2008). Biological apatites are 
predominantly B-CHA with A/B type ratio of 0.7-0.9 (Rey et al., 1989). Higher A/B 
type ratio was observed in old tissues as compared to the young ones, indicating that 
type B carbonate apatite is dominant in young tissues (Landi et al., 2004). 
 
Synthesis method and condition have been reported to affect the type and 
properties of CHA produced. A-CHA, Ca10(PO4)6(OH)2-2x(CO3)x with 0 ≤ x ≤ 1,   is 
commonly synthesized by heating HA at high temperature (800-1000 °C) in dry CO2 
atmosphere for a few hours, where the reaction is presented in Eq. 2.1 (Gibson and 
Bonfield, 2002; Lafon et al., 2008). Each CO32- group substitutes for two OH- group 
so the charge balance is maintained. 
 
Ca10(PO4)6(OH)2 + xCO2 ↔ Ca10(PO4)6(OH)2-2x(CO3)x + xH2O  (Eq. 2.1)  
    
On the other hand, B-CHA are normally obtained from precipitation reaction 
in aqueous media, which gives rise to the chemical formula of Ca10-y(PO4)6-
y(CO3)y(OH)2-y with 0 ≤ y ≤ 2 (Lafon et al., 2008). The charge imbalance of the 
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produced B-CHA can be balanced by introducing sodium carbonate (Na2CO3), as 
reported by Gibson and Bonfield (2002), as shown in Eq. 2.2. In order to mimic the 
natural structure, sodium salts are often used in syntheses, as apatite structure of the 
mineral bone contains Na+ ions which are located in the calcium sites (Lafon et al., 
2008).  
 
Ca10-yNay(PO4)6-y(CO3)y(OH)2 or Na+ + CO32- ↔ Ca2+ + PO43-  (Eq. 2.2) 
 
The CO32- substitution in HA crystal structure is known to alter Ca:P molar 
ratio (Barralet et al., 2002) as well as its crystal lattice properties, due to the size 
difference between PO43-, OH-, and CO32- ions (LeGeros et al., 1969). The 
comparisons between A- and B-type CHA are tabulated in Table 2.6. B-type CHA, 
with lower A/B ratio, is more preferred as compared to A-type as it dissolves without 
changing surface polar property in bioactivity test (Landi et al., 2004). 
 
With a combination of wet chemical reaction followed by sintering under 
CO2 gas atmosphere, AB-type CHA can be yielded with the chemical formula of 
Ca10-y(PO4)6-y(CO3)y(OH)2-y-2x(CO3)x with 0 ≤ y ≤ 2 and 0 ≤ x ≤ y/2, where x and y 
correspond to the A-type and B-type carbonate contents, respectively (Gibson and 
Bonfield, 2002; Lafon et al., 2008). 
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Table 2.6: Comparison of A- and B-type CHA (LeGeros et al., 1969; LeGeros, 1991; 
Ito et al., 1997; Redey et al., 1999; Landi et al., 2004; Slosarczyk et al., 2005; 
Kovaleva et al., 2008; Zyman and Tkachenko, 2011) 
Properties  A-type CHA B-type CHA  
CO32- substitution 
 
OH- site PO43- site 
A/B ratio 
 
Higher Lower 
Most abundant 
species 
 
Old tissues Young tissues 
Preparation  Heating in dry CO2 
atmosphere 
 
Synthesized by wet and dry 
chemical methods 
Synthesis temperature 
 
High (> 800 °C) Low 
Order of solubility 
increment after 
incorporation of one 
CO32- per unit cell in 
HA 
 
1015.9 1011.0 
Unit cell parameters 
 a-axis (Å) 
 c-axis (Å) 
 c/a ratio 
 
 
Expansion (> 9.418) 
Contraction (< 6.884) 
Lower (< 0.73) 
 
Contraction (< 9.418) 
Expansion (> 6.884) 
Higher (> 0.73) 
Millers plane 
 (300) 
 (002) 
 
Shift to lower angle 
Shift to higher angle 
 
 
Shift to higher angle 
Shift to lower angle 
Infrared spectrum 
(CO32- bands) 
 
877-880, 1500, 1540-1545 
cm-1 
870-875, 1410-1430, 1450-
1470 cm-1 
Chemical formula Ca10(PO4)6(OH)2-2x(CO3)x 
with 0 ≤ x ≤1  
 
Ca10-y(PO4)6-y(OH)2-y(CO3)y 
with 0 ≤ y ≤2  
 
Preference  Less preferable, lower 
affinity for human trabecular 
osteoblastic cell as compared 
to HA. 
Preferable, decrease in 
crystallinity and increase in 
solubility without changing 
surface polar property in 
both in vivo and in vitro 
tests. 
 
 
 
23 
 
2.4.2.2 Synthesis of Carbonated Hydroxyapatite by Nanoemulsion 
Parameters such as pH, temperature, chemical nature and concentration of 
starting materials control the chemical properties of the final powder (Vignoles et al., 
1988). Various synthesis methods used to produce nanocrystalline CHA include 
microwave irradiation (Sampath Kumar et al., 2000), mechanochemical (Suchanek et 
al., 2002), hydrothermal (Riman et al., 2002; Jokanoviã et al., 2006), 
mechanochemical-hydrothermal (Riman et al., 2002; Suchanek et al., 2002), 
precipitation (Lafon et al., 2008), nanoemulsion (Zhou et al., 2008), and hydrolysis 
(Pieters et al., 2010). 
 
Nanostructured CHA particles have high surface area which is desirable for 
their use in many fields (including TE) as to imitate bones and teeths architectures. 
Zhou et al. (2008) succeeded in synthesizing nanosized B-CHA by adopting 
nanoemulsion method without addition of any surfactant, and the results suggested it 
was calcium deficient with Ca/P molar ratio less than 1.67.  
 
Basically, emulsion is a mixture of at least two immiscible liquids in which 
one liquid (the dispersed phase) is dispersed in the other (the continuous phase). It is 
classified either as water-in-oil (W/O) or oil-in-water (O/W), depending on which 
phase constitutes the dispersed phase (Forgiarini et al., 2001). Emulsion is a 
thermodynamically unstable liquid/liquid dispersion that is normally stabilized by 
surfactants (typically over 20 wt%). Energy inputs such as shaking, stirring, 
homogenizing or spraying are needed to form an emulsion, and the preparing process 
is termed emulsification. 
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Nanoemulsion, also known as submicron emulsion, consists of fine and 
uniform droplets ranging from 20-500 nm (Solans et al., 2005; Zhou et al., 2008). 
Unlike macroemulsion and microemulsion, nanoemulsion is formed spontaneously, 
where two immiscible fluids with low interfacial tension are brought into contact. 
The principle of this method is that preformed material can precipitate as 
nanospheres when the organic phase (solution water in miscible organic solvent) is 
mixed with aqueous phase (water containing surfactants) (Zhou et al., 2008). In 
biomaterials development where biocompatibility is a crucial requirement, this 
method eliminates the concern of potentially toxic surfactants as lower concentration 
or no surfactants are needed while providing reproducible narrow size distributed 
nanoparticles.  
 
Acetone is one of the common solvents for Ca(NO3)2·4H2O, apart from 
ethanol (EtOH). Cheng et al. (2001) and Liu et al. (2001) had applied ethanol in their 
research of hydroxyapatite (HA) syntheses via sol-gel production route. However, it 
was reported that EtOH is a polar protic solvent, whereby when dissolved with 
Ca(NO3)2·4H2O, some nitrate groups would be substituted by ethoxide groups and 
resulted the formation of Ca(OEt)x(NO3)2-x  which could later be incorporated into 
the apatite structure. Acetone, known as polar aprotic solvent (i.e. dissolves without 
any reaction), was chosen by Zhou et al. (2008) as oil phase in the nanoemulsion 
synthesis, which do not affect the purity of the as-synthesized CHA powder. Besides, 
it exists in normal blood and urine as product of breakdown of body fat in very little 
quantities and its selection as reaction medium mimics the natural process of apatite 
formation (Reisman, 1998; Zhou et al., 2008). 
 
